Maike E. Lindemann1, Vanessa Stebner2, Alexander Tschischka3, Julian Kirchner3, Lale Umutlu4, and Harald H. Quick1,5
1Highfield- and Hybrid MR Imaging, University Hospital Essen, Essen, Germany, 2Department of Nuclear Medicine, University Hospital Essen, Essen, Germany, 3Department of Diagnostic and Interventional Radiology, University Hospital Düsseldorf, Düsseldorf, Germany, 4Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany, 5Erwin L. Hahn Institute for Magnetic Resonance Imaging, Essen, Germany
Synopsis
The study goal is to investigate how the simulated
reduction of injected radiotracer affects PET image quality and quantification
in whole-body PET/MR in patients with oncologic findings. PET data of fifty-one
patients was reconstructed with 4, 3, 2 and 1 minute/bed time interval. Image
quality parameters were analyzed. As expected, the image quality decreases with
shorter PET image acquisition times. Besides the two key factors acquisition
time and injected activity, the image quality is influenced by the BMI. A lower
BMI results in better image quality parameters. 2 minutes acquisition time per
bed is sufficient to provide accurate lesion detection.
Purpose
In contrast to positron emission tomography/computed
tomography (PET/CT) integrated PET/magnetic resonance (PET/MR) inherently
reduces the overall patient radiation dose by replacing the ionizing CT
modality by nonionizing MR imaging [1]. Moreover, the simultaneous data
acquisition in PET/MR provides latitude for further reduction of the radiation
dose. The rather long PET acquisition times to match the prolonged MR
examinations may allow for a decrease in applied radiotracer activity [2]. The
study goal, thus, is to investigate how the simulated reduction of injected
radiotracer affects PET image quality and quantification in whole-body PET/MR
in patients with oncologic findings.Methods
Fifty-one patients with different oncologic findings
underwent a clinical whole-body 18F-Fluorodesoxyglucose
PET/MR examination with 4 min acquisition time per bed position. Detailed
patient information is listed in Tab.1. PET data in list-mode format was
reconstructed with 4, 3, 2, and 1 min/bed time intervals for each patient. The
4-minute PET reconstructions served as reference standard. All whole-body PET
data sets with four time intervals for each patient were reconstructed and
analyzed regarding image quality, lesion detectability, PET quantification and
standardized uptake values. Region-of-interests-analyses were generated in all
detectable lesions, the liver, and in the mediastinal blood pool.
Signal-to-noise ratio, contrast-to-noise ratio and image noise for each
timeframe were calculated. An image quality score was defined
(0 = non-diagnostic, 1 = poor, 2 = moderate, and
3 = good). Results
A
total of 91 lesions were detected in the 4-minute PET reconstructions. The same
number of congruent lesions was also noticed in the 3 and 2 mpb reconstructed
images. A total of 2 lesions in 2 patients was not detected in the 1 minute PET
data reconstructions due to poor image quality. The results of image quality
parameters are shown in Fig.1. The image noise in the liver increased from
18.2 % in the 4 min timeframe to 32.9 % in the 1 min timeframe. The
image quality score decreased from 2.4 at 4 mpb to 1.8 at 1 mpb. The
signal-to-noise ratio also declined with shorter timeframes from 6.4 (4 mpb) to
3.5 (1 mpb). The contrast-to-noise ratio decreased from 20.9 at 4 mpb to 16.5
at 1 mpb. SUVmean and SUVmax showed no significant
changes between 4 and 1 mpb reconstructed timeframes. Fig.2 depicts the
overview of SUVs and SNR of detected lesion in four different body regions. In
the head/neck region the differences in SUVs and SNR between 4 mpb and shorter
reconstructed acquisition times is highest. The impact of reduced PET
acquisition times on image quality and quantification parameters is lower for
the thorax and pelvic body regions. Table 2 shows, that a lower BMI, a short
time interval between activity injection and PET/MR examination and a higher
activity are optimal conditions to obtain high image quality regardless of
different PET reconstruction times. Besides the two key factors acquisition
time and injected activity, the image quality is influenced by the BMI (Figure
3). A lower BMI results in better image quality parameters. Fig.4 depicts a
patient example of consistently high image quality scores even in shorter
imaging duration. The lesion is detectable in all image reconstructions. Fig.5
shows a patient example of significantly decreasing image quality with shorter
PET acquisition times. The marked lesion is not detectable in in the 1 mpb
reconstruction.Discussion and Conclusion
The study setup with retrospective reconstruction of
PET data in list-mode format into different time-intervals allowed for a
systematic and controlled evaluation of image quality and quantitative parameters.
This allows eliminating numerous confounding factors that would have been present
when multiple tracer injections and PET re-examinations would have been
performed [3]. As expected, the image quality decreases with shorter PET image
acquisition times. Besides the two key factors acquisition time and injected
activity, the image quality is influenced by the BMI. A lower BMI results in
better image quality parameters. Reconstruction of whole-body PET data with
different time intervals has shown that 2 minutes instead of 4 minutes
acquisition time per bed position is sufficient to provide accurate lesion
detection, high image quality, SNR and CNR despite the trends to lower image
quality with shorter PET acquisition times [4]. This result provides the
foundation for the potential to reduce the PET acquisition time in fast 18F-FDG
whole-body PET/MR imaging protocols [5, 6]. Another conclusion of this study is
that radiotracer dose may be further reduced in 18F-FDG whole-body PET/MR in
patients with oncologic findings while maintaining high image quality and
accurate PET quantification.Acknowledgements
No acknowledgement found.References
1. Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body
PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J. Nucl. Med.
2012; 53:845-855.
2. Oehmigen M, Ziegler S, Jakoby BW, Georgi JC, Paulus DH, Quick HH. Radiotracer dose reduction
in integrated PET/MR: implications from national electrical manufacturers
association phantom studies. J. Nucl. Med. 2014; 55:1361-1367.
3. Gatidis S, Würslin C, Seith F, et al. Towards tracer dose
reduction in PET studies: Simulation of dose reduction by retrospective
randomized undersampling of list-mode data. Hell. J. Nucl. Med. 2016; 19:15-18.
4. Hartung-Knemeyer V, Beiderwellen KJ, Buchbender C, et al. Optimizing positron emission tomography image
acquisition protocols in integrated positron emission tomography/magnetic
resonance imaging. Invest. Radiol. 2013; 48:290-294.
5. Grueneisen J, Schaarschmidt BM, Heubner M, et al. Implementation
of FAST-PET/MRI for whole-body
staging of female patients with recurrent pelvic malignancies: A comparison to
PET/CT. Eur J Radiol.
2015 Nov;84(11):2097-102
6. Kirchner J, Sawicki LM, Suntharalingam S, et al. Whole-body
staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to
18F-FDG PET/CT and CT. PLoS One. 2017
Feb 22;12(2):e0172553.